Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Laekna Therapeutics
company
About
Laekna Therapeutics is a biotech company focusing on drug discovery and development.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $18.50M
- Industries
- Biotechnology
- Founded date
- Dec 1, 2016
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Laekna Therapeutics is a startup biotech company focusing on innovative drug discovery and development. Targeting large unmet medical needs, Laekna is dedicated to developing new therapies for cancer and liver diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$79.50M
Laekna Therapeutics has raised a total of
$79.50M
in funding over 2 rounds. Their latest funding was raised on
May 18, 2022 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 18, 2022 | Series D | $61M | 1 | — | — | Detail |
| Jun 4, 2018 | Series A | $18.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Laekna Therapeutics is funded by 2 investors.
Infinity Capital
and Anlongmed Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Infinity Capital
|
— | Series D |
Anlongmed Fund
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
